rhuFVIIa in Post-partum Hemorrhage

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2007
The aim of this clinical research project is to evaluate the use of the recombinant human activated factor VII (rhFVIIa), given as a salvage therapy, in women with a dramatic postpartum hemorrhage still ongoing after all the currently available medical and surgical treatments. We are going to compare its early use, before elective surgery or arterial embolization, to its late use, after embolization or surgery, before salvage hysterectomy.
Epistemonikos ID: 020d79aed84ec46deb476549bc4ab29951426f3a
First added on: May 04, 2024